Literature DB >> 23265607

Dissecting the immunological, antimicrobial and clinical effects of vitamin D therapy in tuberculosis.

Ajit Lalvani1, David W Connell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23265607      PMCID： PMC4001618          DOI： 10.1179/2047772412Z.00000000087

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN： 2047-7724            Impact factor:   2.894


× No keyword cloud information.
  7 in total

1.  Innate immunity to TB: a druggable balancing act.

Authors:  Ajit Lalvani; Marcel A Behr; Saranya Sridhar
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

2.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

3.  Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial.

Authors:  Davaasambuu Ganmaa; Edward Giovannucci; Barry R Bloom; Wafaie Fawzi; Winthrop Burr; Dulguun Batbaatar; Nyamjav Sumberzul; Michael F Holick; Walter C Willett
Journal:  Am J Clin Nutr       Date:  2012-07-03       Impact factor: 7.045

4.  Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study.

Authors:  R J Wilkinson; M Llewelyn; Z Toossi; P Patel; G Pasvol; A Lalvani; D Wright; M Latif; R N Davidson
Journal:  Lancet       Date:  2000-02-19       Impact factor: 79.321

5.  High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.

Authors:  Adrian R Martineau; Peter M Timms; Graham H Bothamley; Yasmeen Hanifa; Kamrul Islam; Alleyna P Claxton; Geoffrey E Packe; John C Moore-Gillon; Mathina Darmalingam; Robert N Davidson; Heather J Milburn; Lucy V Baker; Richard D Barker; Nicholas J Woodward; Timothy R Venton; Korina E Barnes; Christopher J Mullett; Anna K Coussens; Clare M Rutterford; Charles A Mein; Geraint R Davies; Robert J Wilkinson; Vladyslav Nikolayevskyy; Francis A Drobniewski; Sandra M Eldridge; Christopher J Griffiths
Journal:  Lancet       Date:  2011-01-05       Impact factor: 79.321

Review 6.  Vitamin D in the treatment of pulmonary tuberculosis.

Authors:  Adrian R Martineau; Friedemann U Honecker; Robert J Wilkinson; Christopher J Griffiths
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-12       Impact factor: 4.292

7.  Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment.

Authors:  Anna K Coussens; Robert J Wilkinson; Yasmeen Hanifa; Vladyslav Nikolayevskyy; Paul T Elkington; Kamrul Islam; Peter M Timms; Timothy R Venton; Graham H Bothamley; Geoffrey E Packe; Mathina Darmalingam; Robert N Davidson; Heather J Milburn; Lucy V Baker; Richard D Barker; Charles A Mein; Leena Bhaw-Rosun; Rosamond Nuamah; Douglas B Young; Francis A Drobniewski; Christopher J Griffiths; Adrian R Martineau
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205
  7 in total
  3 in total

1.  Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk of TB progression in Gambian adults.

Authors:  Olumuyiwa Owolabi; Schadrac Agbla; Patrick Owiafe; Simon Donkor; Toyin Togun; Abdou K Sillah; Martin O C Ota; Jayne S Sutherland
Journal:  Tuberculosis (Edinb)       Date:  2016-03-03       Impact factor: 3.131

Review 2.  A review of Vitamin D effects on common respiratory diseases: Asthma, chronic obstructive pulmonary disease, and tuberculosis.

Authors:  Mohammad Esmaeil Hejazi; Faezeh Modarresi-Ghazani; Taher Entezari-Maleki
Journal:  J Res Pharm Pract       Date:  2016 Jan-Mar

Review 3.  Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.

Authors:  Rodrigo Abreu; Pramod Giri; Fred Quinn
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.